QQ客服 官方微博 反馈留言

	Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor D-1-methyl-tryptophan
	Zhang, Xiaolong; Yang, Yuanyuan; Zhang, Leisheng; Lu, Yang; Zhang, Qing; Fan, Dongmei; Zhang, Yizhi; Zhang, Yanjun; Ye, Zhou; Xiong, Dongsheng
	2017
卷号	10期号:1页码:56
关键词	MSCs Bispecific antibodies CD3 CD19 D-1-methyl-tryptophan B cell lymphoma
ISSN号	1756-8722
DOI	10.1186/s13045-017-0397-z
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6368311
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Zhang, Xiaolong,Yang, Yuanyuan,Zhang, Leisheng,et al. Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor D-1-methyl-tryptophan[J],2017,10(1):56.
APA	Zhang, Xiaolong.,Yang, Yuanyuan.,Zhang, Leisheng.,Lu, Yang.,Zhang, Qing.,...&Xiong, Dongsheng.(2017).Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor D-1-methyl-tryptophan.,10(1),56.
MLA	Zhang, Xiaolong,et al."Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor D-1-methyl-tryptophan".10.1(2017):56.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。